| Serial Number | 90673637 |
| Word Mark | GENE THERAPY READY |
| Filing Date | Tuesday, April 27, 2021 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, December 20, 2022 |
| Registration Number | 6927368 |
| Registration Date | Tuesday, December 20, 2022 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, October 4, 2022 |
| Goods and Services | organizing and administering a network of research sites, namely, business management in the field of clinical trials, specifically, providing governmental registration assistance in the nature of regulatory submission management on behalf of research sites that conduct gene therapy and vaccine research to assist them with clinical research and clinical trials; providing institutional biosafety committee services, namely, providing independent review and oversight of clinical trials involving genetically engineered gene therapy and vaccine research for business purposes |
| Goods and Services | Providing institutional biosafety committee services, namely, providing independent review and oversight of clinical trials involving genetically engineered gene therapy and vaccine research, specifically, reviewing research protocols and related information to ensure protection of the rights and welfare of human subjects of research; assessing the readiness of research sites to conduct gene therapy and vaccine research, namely, reviewing standards and practices to assure compliance with laws and regulations in the field of clinical trials involving human subjects |
| Disclaimer with Predetermined Text | "GENE THERAPY" |
| Goods and Services | Providing institutional biosafety committee services, namely, providing independent review and oversight of clinical trials involving genetically engineered gene therapy and vaccine research, specifically, evaluating research sites involved in gene therapy and vaccine research clinical trials to determine whether the organizations conform to an established accreditation standard; assessing the readiness of research sites to conduct gene therapy and vaccine research, namely, testing, analysis, and evaluation of gene therapy and vaccine research service providers to determine conformity with established accreditation standards |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, August 29, 2022 |
| Primary Code | 035 |
| First Use Anywhere Date | Tuesday, January 19, 2021 |
| First Use In Commerce Date | Tuesday, January 19, 2021 |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, August 2, 2021 |
| Primary Code | 042 |
| First Use Anywhere Date | Tuesday, January 19, 2021 |
| First Use In Commerce Date | Tuesday, January 19, 2021 |
| International Class | 045 - Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, July 29, 2022 |
| Primary Code | 045 |
| First Use Anywhere Date | Tuesday, January 19, 2021 |
| First Use In Commerce Date | Tuesday, January 19, 2021 |
| Party Name | Advarra, Inc. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | Columbia, MD 21044 |
| Party Name | Advarra, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Columbia, MD 21044 |
| Party Name | Advarra, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Columbia, MD 21044 |
| Event Date | Event Description |
| Wednesday, January 25, 2023 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| Tuesday, December 20, 2022 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Tuesday, December 20, 2022 | REGISTERED-PRINCIPAL REGISTER |
| Wednesday, November 2, 2022 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| Tuesday, October 4, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, October 4, 2022 | PUBLISHED FOR OPPOSITION |
| Wednesday, September 14, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Monday, August 29, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Monday, August 29, 2022 | EXAMINER'S AMENDMENT ENTERED |
| Monday, August 29, 2022 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Monday, August 29, 2022 | EXAMINERS AMENDMENT E-MAILED |
| Monday, August 29, 2022 | EXAMINERS AMENDMENT -WRITTEN |
| Friday, July 29, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, July 29, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, July 29, 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, February 11, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, February 11, 2022 | NON-FINAL ACTION E-MAILED |
| Friday, February 11, 2022 | NON-FINAL ACTION WRITTEN |
| Thursday, December 23, 2021 | ASSIGNED TO EXAMINER |
| Friday, September 24, 2021 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Friday, September 24, 2021 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Friday, September 24, 2021 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Monday, August 2, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, April 30, 2021 | NEW APPLICATION ENTERED |